{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "18",
          "submission_status": "AP",
          "submission_status_date": "20100930",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "57",
          "submission_status": "AP",
          "submission_status_date": "20260310",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85334",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/125249Orig1s057lbl.pdf",
              "date": "20260312",
              "type": "Label"
            },
            {
              "id": "85335",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/125249Orig1s057ltr.pdf",
              "date": "20260312",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "49",
          "submission_status": "AP",
          "submission_status_date": "20210318",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "66812",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125249s049lbl.pdf",
              "date": "20210319",
              "type": "Label"
            },
            {
              "id": "66823",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/125249Orig1s049ltr.pdf",
              "date": "20210322",
              "type": "Letter"
            },
            {
              "id": "81541",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/125249Orig1s049.pdf",
              "date": "20250312",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20080227",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "39876",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf",
              "date": "20080311",
              "type": "Label"
            },
            {
              "id": "43311",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/125249s000TOC.html",
              "date": "20080502",
              "type": "Review"
            },
            {
              "id": "31869",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/125249s000ltr.pdf",
              "date": "20080409",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "47",
          "submission_status": "AP",
          "submission_status_date": "20201218",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "65628",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125249s047lbl.pdf",
              "date": "20201221",
              "type": "Label"
            },
            {
              "id": "65672",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125249Orig1s047ltr.pdf",
              "date": "20201223",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "45",
          "submission_status": "AP",
          "submission_status_date": "20200212",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "64090",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125249s045lbl.pdf",
              "date": "20200724",
              "type": "Label"
            },
            {
              "id": "64097",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/125249Orig1s045ltr.pdf",
              "date": "20200727",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA125249",
      "sponsor_name": "KINIKSA PHARMACEUTICALS (UK), LTD.",
      "openfda": {
        "application_number": [
          "BLA125249"
        ],
        "brand_name": [
          "ARCALYST"
        ],
        "generic_name": [
          "RILONACEPT"
        ],
        "manufacturer_name": [
          "Kiniksa Pharmaceuticals (UK), Ltd."
        ],
        "product_ndc": [
          "73604-914"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "RILONACEPT"
        ],
        "rxcui": [
          "763453",
          "763457"
        ],
        "spl_id": [
          "11e22c54-9b9a-4f9f-8680-cb7327511a23"
        ],
        "spl_set_id": [
          "ad965f38-dd22-4607-a673-2fb92f3b527a"
        ],
        "package_ndc": [
          "73604-914-04",
          "73604-914-01"
        ],
        "unii": [
          "8K80YB5GMG"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ARCALYST",
          "active_ingredients": [
            {
              "name": "RILONACEPT",
              "strength": "220MG"
            }
          ],
          "dosage_form": "VIAL",
          "route": "SINGLE-USE",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}